SGLT2 inhibitors mitigate kidney tubular metabolic and mTORC1 perturbations in youth-onset type 2 diabetesJennifer A. Schaub(University of Michigan), Petter Bjornstad(University of Colorado Denver)Journal of Clinical InvestigationJanuary 13, 202310.1172/jci164486Cited by 103SaveCiteExport RISWatch citationsRelated PapersRationale and design of the Kidney Precision Medicine Project|Kidney International|2021|187Integrated multiomics implicates dysregulation of ECM and cell adhesion pathways as drivers of severe COVID-associated kidney injury|medRxiv|2024|0